Madrigal Pharmaceuticals Inc (MDGL)
326.00
-5.32
(-1.61%)
USD |
NASDAQ |
Nov 05, 09:44
Madrigal Pharmaceuticals 1 Year Total Returns (Daily): 125.6% for Nov. 4, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 04, 2024 | 125.6% |
November 01, 2024 | 134.1% |
October 31, 2024 | 97.40% |
October 30, 2024 | 71.17% |
October 29, 2024 | 80.89% |
October 28, 2024 | 80.23% |
October 25, 2024 | 70.74% |
October 24, 2024 | 60.57% |
October 23, 2024 | 60.80% |
October 22, 2024 | 54.77% |
October 21, 2024 | 58.80% |
October 18, 2024 | 57.56% |
October 17, 2024 | 49.78% |
October 16, 2024 | 52.89% |
October 15, 2024 | 54.00% |
October 14, 2024 | 53.47% |
October 11, 2024 | 54.15% |
October 10, 2024 | 40.94% |
October 09, 2024 | 50.61% |
October 08, 2024 | 53.87% |
October 07, 2024 | 52.49% |
October 04, 2024 | 53.51% |
October 03, 2024 | 46.73% |
October 02, 2024 | 45.89% |
October 01, 2024 | 43.34% |
Date | Value |
---|---|
September 30, 2024 | 45.32% |
September 27, 2024 | 40.24% |
September 26, 2024 | 43.61% |
September 25, 2024 | 43.24% |
September 24, 2024 | 45.47% |
September 23, 2024 | 47.20% |
September 20, 2024 | 44.65% |
September 19, 2024 | 43.05% |
September 18, 2024 | 42.54% |
September 17, 2024 | 32.67% |
September 16, 2024 | 32.69% |
September 13, 2024 | 26.98% |
September 12, 2024 | 32.73% |
September 11, 2024 | 25.95% |
September 10, 2024 | 19.90% |
September 09, 2024 | 21.42% |
September 06, 2024 | 31.56% |
September 05, 2024 | 33.33% |
September 04, 2024 | 32.52% |
September 03, 2024 | 27.69% |
August 30, 2024 | 38.77% |
August 29, 2024 | 38.57% |
August 28, 2024 | 38.69% |
August 27, 2024 | 42.10% |
August 26, 2024 | 42.65% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-56.47%
Minimum
Nov 07 2019
418.0%
Maximum
Jan 27 2023
39.23%
Average
1.12%
Median
1 Year Total Returns (Daily) Benchmarks
ACADIA Pharmaceuticals Inc | -39.26% |
Sarepta Therapeutics Inc | 57.76% |
ADMA Biologics Inc | 423.6% |
Intra-Cellular Therapies Inc | 56.70% |
Entrada Therapeutics Inc | 6.64% |